A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markers

Sarkis Hamalian(California State University, Northridge), Jonathan A. Kelber(University of California, San Diego), Julia Tchou(University of Pennsylvania), Francesca Sanchez(California State University, Northridge), Eric Vickers(California State University, Northridge), Farhana Runa(California State University, Northridge), Tuan M. Nguyen(Broad Institute), Robert Güth(California State University, Northridge), Jonathan D. Humphries(Manchester Academic Health Science Centre), Joshua Gamez(California State University, Northridge), Anupma Nayak(Hospital of the University of Pennsylvania), Megan J. Agajanian(California State University, Northridge), Martin J. Humphries(National Institutes of Health), Justin Molnar(California State University, Northridge), Ioannis K. Zervantonakis(UPMC Hillman Cancer Center)
Oncogene
July 8, 2021
Cited by 30


Related Papers